Science Explorer Back to mapMap
Discussion
Researcher · Memorial Sloan Kettering Cancer Center · United States

Lu Wang

Lu Wang publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Sarcoma Diagnosis and Treatment.

ORCID 0000-0002-0073-0666 OpenAlex
World rank
#220,871
of 7,710,434 ranked researchers
Rank in United States
#81,713
of 1,627,098
Works
1,223
Citations
27k
Citations per work
22.5
h-index
82
i10-index 398Top 0.6% in Molecular Biology
Lu Wang

What does Lu Wang research?

Lu Wang's work is mostly in Biochemistry, Genetics and Molecular Biology (24%), Medicine (23%).

Everything else: 646 works · 52.8% of their workLife Sciences: 300 works · 24.5% of their workBiochemistry, Genetics and Molecular Biology: 300 works · 24.5% of their workMolecular Biology: 192 works · 15.7% of their workCancer Research: 54 works · 4.4% of their workGenetics: 54 works · 4.4% of their workHealth Sciences: 278 works · 22.7% of their workMedicine: 278 works · 22.7% of their workPulmonary and Respiratory Medicine: 104 works · 8.5% of their workOncology: 91 works · 7.4% of their workSurgery: 83 works · 6.8% of their workTHEIR WORKLu Wang1,223works
Life Sciences24%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else64652.8%
    1. Biochemistry, Genetics and Molecular Biology30024.5%
    1. Medicine27822.7%
  1. 1Molecular Biology16% of their works
  2. 2Pulmonary and Respiratory Medicine8% of their works
  3. 3Oncology7% of their works
  4. 4Surgery7% of their works
  5. 5Genetics4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Lu Wang's research?

The keywords of their largest research topics: Targeted Therapy, Prognostic Factors, Clinical Trials, Chemotherapy, Cancer Genomics, Mutational Signatures, Immunotherapy and ALK Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Targeted Therapy1313 topics
  2. Prognostic Factors1113 topics
  3. Clinical Trials752 topics
  4. Chemotherapy712 topics
  5. Cancer Genomics561 topic
  6. Mutational Signatures561 topic
  7. Immunotherapy552 topics
  8. ALK Inhibitors481 topic
  9. EGFR Mutations481 topic
  10. Osteosarcoma441 topic
  11. Soft Tissue Sarcoma441 topic
  12. AML401 topic
  13. Acute Myeloid Leukemia401 topic
  14. RNA methylation381 topic
  15. m6A-seq381 topic
  16. Glioblastoma281 topic
  17. Temozolomide281 topic
  18. Genomic Profiles271 topic
  19. Small-Cell Lung Cancer271 topic
  20. DNA Methylation241 topic
  21. Histone Modification241 topic

Where does Lu Wang work?

Lu Wang's main affiliation in the publication record is Memorial Sloan Kettering Cancer Center, United States.

How many publications and citations does Lu Wang have?

OpenAlex counts 1,223 works and 27,492 citations for Lu Wang, an h-index of 82, ranking #220,871 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Lu Wang

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lu Wang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.